Viewing Study NCT03524820


Ignite Creation Date: 2025-12-25 @ 4:11 AM
Ignite Modification Date: 2025-12-26 @ 3:09 AM
Study NCT ID: NCT03524820
Status: TERMINATED
Last Update Posted: 2022-08-04
First Post: 2018-03-07
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Cetuximab Therapy for Third Line Rechallenge in Metastatic Colorectal Cancer
Sponsor: Hadassah Medical Organization
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module